Glycated Hemoglobin Analysis of Diabetic Patients Diagnosed from 2006 to 2008 at the National Children's Hospital
DOI:
https://doi.org/10.51481/amc.v53i2.730Keywords:
Diabetes Mellitus, glicosilated hemoglobina, diabetic child, diabetic adolescentAbstract
Aim: Glycated hemoglobin has been used as one of the main tools to achieve a successful control of diabetes mellitus. This study's aim is to describe glycated hemoglobin values from diabetic patients followed at the National Children's Hospital, who were diagnosed during the 2006 - 2008 period. Methods:Observational descriptive study of 115 diabetic patients in control at the National Children's Hospital, diagnosed during the 2006 - 2008. Average glycated hemoglobin values at the time of diagnosis and in subsequent control were established. Percentage of success in glycated hemoglobin goals, as defi ned by the American Diabetes Association, was also obtained. Microsoft Excel 2003 was used for data processing.
Results: Of the 115 patients, 79.13% are type1 diabetics, 16,52% type 2, and 4.35% other types. Average glycated hemoglobin values was 7.05% from 0-6 years, 6.87% from 6-12 years, and 7.04% over 12 years. Average values correspond to 7.03% for type1, 7.04% for type2, and 6.45% others. The percentage of success in glycated hemoglobin goals are 90,00% from 0-6 years, 90.47% from 6-12 years, and 66.66% over 12 years. The general success percentage is 85.71%.
Conclusions: Type1 diabetes continues to be the most frequent diagnosis, nevertheless type 2 diabetics are increasing in the Costarrican pediatric population. The diabetic patients that receive their control at the National Children's Hospital present glycated hemoglobin average values that comply with the ADA's proposed success goals.
Downloads
References
Calzada LD. Diabetes Mellitus Tipo 1. En: Diabetes Mellitus en Costa Rica. Primera ed. Laboratorios Stein, San José 2006; 89-99.
American Diabetes Association ADA. Standards of medical care in diabetes. Diabetes Care. 2010;33: S13-S61.
Rohlfi ng C, England J, Wiedmeyer H, Tennill A, Little R, Goldstein D. Defi ning the relationship between plasma glucose and HbA1c. Diabetes Care 2002; 25: 275-278.
Sacks D, Bruns D, Goldstein D, Maclaren N, McDonald J, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clinical Chemistry 2002; 48: 436-472.
Wild S, Roglic G, Green A, Sicree R, King H,. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
King H, Aubert RE, Herman WH. Global burden of diabetes, 19952025: prevalence, numerical estimates and projections. Diabetes Care 1998; 21: 1414-31.
SEARCH for Diabetes in Youth Study Group. The burden of diabetes mellitus among US youth: Prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics 2006;118:1510-1518.
Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, et al. Care of Children and Adolescents With Type 1 Diabetes. Diabetes Care 2005; 28: 186-212.
Ogden C, Flegal K, Carroll M, Johnson C. Prevalence and Trends in Overweight Among US Children and Adolescents, 1999-2000. JAMA 2002, 288: 1728-1732.
Weiss R, Dziura J,Burgert T, Tamborlane W, Taksali S, Yeckel C, et al. Obesity and the metabolic syndrome in children and adolescents. NEJM 2004, 350: 2362-2374.
Copeland K, Becker D, Gottschalk M, Hale D. Type 2 Diabetes in Children and Adolescents: Risk Factors, Diagnosis, and Treatment. Clinical Diabetes 2005, 23: 181-185.
Fagot-Campagna A, Pettitt D, Engelgau M, Ríos N, Geiss L, Valdez R, et al. Type 2 diabetes among North American children and adolescents: An epidemiologic review and a public health perspective. J Pediatrics 2000; 136: 664-672.
Morice A, Achio M. Tendencias, costos y desafíos para la atención de las enfermedades crónicas en Costa Rica. Rev. Cienc. Adm. Financ. Segur. Soc. 2003; 11:18-34.
Richmond E, Calzada L, Jaramillo O, Fuscaldo C, Artavia E, Chen C. Pediatric Type 1 Diabetes Mellitus in Costa Rica: clinical presentation, complications and glycemic control 1999-2001. Poster session presented at: The Endocrine Society's 85th Annual Meeting; 2003: June 19 - 22; Philadelphia, Pennsylvania.
Laffel M, Svoren B, Butler D, Levine B, Anderson B, Lori. Reducing Acute Adverse Outcomes in Youths With Type 1 Diabetes: A Randomized, Controlled Trial. Pediatrics 2003;112: 914-922
American Diabetes Association. Type 2 Diabetes in Children and Adolescents. Pediatrics 2000;105: 671-680.
Downloads
Published
Issue
Section
License
Copyright (c) 2011 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
